• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[放射治疗联合博宁治疗乳腺癌溶骨性转移的经验]

[An experience with combined therapy of radiation and Bonephos for osteolytic metastases of breast cancer].

作者信息

Poliakov P Iu, Larionova N A, Bychenkov O A, Moc'kin V G

机构信息

M.F.Vladimirsky Research Clinical Institute, Ministry of Health of the RF, Moscow Region.

出版信息

Vopr Onkol. 1999;45(3):311-3.

PMID:10443239
Abstract

A new procedure of conservative treatment (radiation + benephos) is suggested to improve the quality of life of cancer patients with osteolytic metastases. Radiation regimen, dosage, benephos administration methods and characteristics of combined therapy are discussed. The procedure was tested in the course of the treatment of 21 breast cancer patients with osteolytic metastases. According to preliminary results, the treatment is easy to tolerate; it produced stable analgetic effect (2-9 months) in 85.7%, as compared with 42.1% in the control group.

摘要

建议采用一种新的保守治疗方法(放疗 + 氯膦酸盐)来提高骨溶解性转移癌患者的生活质量。文中讨论了放疗方案、剂量、氯膦酸盐给药方法以及联合治疗的特点。该方法在 21 例患有骨溶解性转移的乳腺癌患者的治疗过程中进行了测试。根据初步结果,该治疗易于耐受;85.7% 的患者产生了稳定的镇痛效果(2 - 9 个月),而对照组这一比例为 42.1%。

相似文献

1
[An experience with combined therapy of radiation and Bonephos for osteolytic metastases of breast cancer].[放射治疗联合博宁治疗乳腺癌溶骨性转移的经验]
Vopr Onkol. 1999;45(3):311-3.
2
[Randomized trial of two administration schedule of bonephos (Clodronate) in patients with painful bone metastasis].[骨膦(氯膦酸盐)两种给药方案治疗骨转移疼痛患者的随机试验]
Vopr Onkol. 1998;44(6):725-8.
3
[Double-blinded controlled study comparing clodronate versus placebo in patients with breast cancer bone metastases].[氯膦酸盐与安慰剂对比治疗乳腺癌骨转移患者的双盲对照研究]
Bull Cancer. 2001 Jul;88(7):701-7.
4
Disodium clodronate in the treatment of pain due to bone metastases.氯膦酸二钠治疗骨转移引起的疼痛。
Int J Clin Pharmacol Res. 1990;10(4):243-6.
5
Treatment of skeletal disease in breast cancer: a controlled clodronate trial.乳腺癌骨疾病的治疗:一项氯膦酸盐对照试验
Bone. 1987;8 Suppl 1:S53-6.
6
Prostate cancer and bone metastases. The effect of clodronate.
Ann Chir Gynaecol. 1998;87(1):59-60.
7
Clodronate for osteolytic metastases due to breast cancer.氯膦酸盐用于治疗乳腺癌所致的溶骨性转移。
Biomed Pharmacother. 1988;42(2):111-6.
8
Phase II trial evaluating the palliative benefit of second-line zoledronic acid in breast cancer patients with either a skeletal-related event or progressive bone metastases despite first-line bisphosphonate therapy.一项II期试验,评估二线唑来膦酸对一线双膦酸盐治疗后出现骨相关事件或骨转移进展的乳腺癌患者的姑息治疗效果。
J Clin Oncol. 2006 Oct 20;24(30):4895-900. doi: 10.1200/JCO.2006.05.9212. Epub 2006 Sep 25.
9
No value of oral clodronic acid in malignant osteolysis.口服氯膦酸在恶性骨溶解中无价值。
Prescrire Int. 1998 Aug;7(36):104.
10
Current and future status of adjuvant therapy for breast cancer.乳腺癌辅助治疗的现状与未来发展态势
Cancer. 2003 Feb 1;97(3 Suppl):880-6. doi: 10.1002/cncr.11124.